Merck & Co., Inc.
US ˙ NYSE ˙ US58933Y1055

SecurityMRK / Merck & Co., Inc.
InstitutionBartlett & Co. LLC
Latest Disclosed Ownership215,001 shares
Latest Disclosed Value $ 23,547
Bartlett & Co. LLC reports 1.76% increase in ownership of MRK / Merck & Co., Inc.

On January 8, 2024 - Bartlett & Co. LLC filed a 13F-HR form disclosing ownership of 215,001 shares of Merck & Co., Inc. (US:MRK) valued at $23,439,409 USD as of December 31, 2023. The entity filed a previous 13F-HR on October 10, 2023 disclosing 211,278 shares of Merck & Co., Inc.. This represents a change in shares of 1.76% during the quarter. The current value of the position is $25,969,971 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-01-08 2023-12-31 13F Merck COM 58933Y105 215,001 3,723 1.76 24 9.52 0.3823
2023-10-10 2023-09-30 13F Merck COM 58933Y105 211,278 -9,720 -4.40 22 -16.00 0.3933
2023-07-14 2023-06-30 13F Merck COM 58933Y105 220,998 38,871 21.34 26 31.58 0.4439
2023-04-06 2023-03-31 13F Merck COM 58933Y105 182,127 7,624 4.37 20 0.00 0.3768
2023-01-04 2022-12-31 13F Merck COM 58933Y105 174,503 -328 -0.19 19 -99.87 0.3920
2022-10-17 2022-09-30 13F Merck COM 58933Y105 174,831 659 0.38 15,177 -5.14 0.3262
2022-08-02 2022-06-30 13F Merck COM 58933Y105 174,172 -1,437 -0.82 16,000 10.14 0.3241
2022-05-13 2022-03-31 13F Merck COM 58933Y105 175,609 -2,333 -1.31 14,527 5.60 0.2539
2022-03-08 2021-12-31 13F Merck COM 58933Y105 177,942 17,419 10.85 13,756 14.09 0.2333
2021-10-15 2021-09-30 13F Merck COM 58933Y105 160,523 6,697 4.35 12,057 0.79 0.2300
2021-07-19 2021-06-30 13F Merck COM 58933Y105 153,826 -3,491 -2.22 11,963 -1.36 0.2283
2021-04-19 2021-03-31 13F Merck COM 58933Y105 157,317 380 0.24 12,128 -5.52 0.2440
2021-01-20 2020-12-31 13F Merck COM 58933Y105 156,937 -1,108 -0.70 12,837 -2.08 0.2740
2020-10-20 2020-09-30 13F Merck COM 58933Y105 158,045 331 0.21 13,110 7.49 0.3077
2020-08-03 2020-06-30 13F Merck COM 58933Y105 157,714 -24 -0.02 12,196 0.49 0.3186
2020-05-07 2020-03-31 13F Merck COM 58933Y105 157,738 -5,808 -3.55 12,136 -11.85 0.3698
2019-11-04 2019-09-30 13F Merck COM 58933Y105 163,546 67,472 70.23 13,767 70.89 0.3615
2019-07-24 2019-06-30 13F Merck COM 58933Y105 96,074 6,271 6.98 8,056 7.86 0.3006
2019-04-23 2019-03-31 13F Merck COM 58933Y105 89,803 -999 -1.10 7,469 7.65 0.2861
2019-01-23 2018-12-31 13F Merck COM 58933Y105 90,802 -1,809 -1.95 6,938 5.60 0.2958
2018-10-15 2018-09-30 13F Merck COM 58933Y105 92,611 561 0.61 6,570 17.59 0.2465
2018-07-31 2018-06-30 13F Merck COM 58933Y105 92,050 3,259 3.67 5,587 15.53 0.2272
2018-04-25 2018-03-31 13F Merck COM 58933Y105 88,791 9,467 11.93 4,836 8.33 0.1997
2018-01-19 2017-12-31 13F Merck COM 58933Y105 79,324 217 0.27 4,464 -11.87 0.1777
2017-10-23 2017-09-30 13F Merck COM 58933Y105 79,107 4,030 5.37 5,065 5.26 0.2122
2017-07-18 2017-06-30 13F Merck COM 58933Y105 75,077 -460 -0.61 4,812 0.25 0.2164
2017-04-25 2017-03-31 13F Merck COM 58933Y105 75,537 -490 -0.64 4,800 7.24 0.2183
2017-02-06 2016-12-31 13F Merck COM 58933Y105 76,027 -810 -1.05 4,476 -6.65 0.2112
2016-10-24 2016-09-30 13F Merck COM 58933Y105 76,837 -1,425 -1.82 4,795 6.34 0.2313
2016-07-27 2016-06-30 13F Merck COM 58933Y105 78,262 4,169 5.63 4,509 15.03 0.2226
2016-05-02 2016-03-31 13F Merck COM 58933Y105 74,093 -2,515 -3.28 3,920 -3.11 0.1966
2016-02-04 2015-12-31 13F Merck COM 58933Y105 76,608 450 0.59 4,046 7.58 0.2087
2015-11-02 2015-09-30 13F Merck COM 58933Y105 76,158 2,950 4.03 3,761 -9.76 0.2062
2015-08-03 2015-06-30 13F Merck COM 58933Y105 73,208 744 1.03 4,168 0.07 0.2090
2015-05-01 2015-03-31 13F Merck COM 58933Y105 72,464 72,464 0.00 4,165 0.2069
2015-01-30 2014-12-31 13F Merck COM 58933Y105 0 -74,093 -100.00 0 -100.00
2014-10-27 2014-09-30 13F Merck COM 58933Y105 74,093 -4,355 -5.55 4,392 -3.22 0.2122
2014-08-01 2014-06-30 13F Merck COM 58933Y105 78,448 1,796 2.34 4,538 4.27 0.2185
2014-05-05 2014-03-31 13F Merck COM 58933Y105 76,652 -2,665 -3.36 4,352 9.62 0.2165
2014-02-05 2013-12-31 13F Merck COM 58933Y105 79,317 -3,580 -4.32 3,970 0.58 0.1985
2013-11-04 2013-09-30 13F Merck COM 58933Y105 82,897 -3,805 -4.39 3,947 -1.99 0.2139
2013-07-30 2013-06-30 13F Merck COM 58933Y105 86,702 86,702 4,027 0.2217
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.